| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $23.1M | +65.5% |
| SG&A Expense | $7.8M | +68.8% |
| Operating Income | -$30.9M | -9.1% |
| Net Income | -$28.0M | +7.4% |
| EPS (Basic) | -$0.83 | +28.4% |
| EPS (Diluted) | -$0.83 | +28.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $19.6M | -49.5% |
| Current Assets | $20.4M | -48.5% |
| Total Assets | $21.5M | -46.6% |
| Current Liabilities | $12.7M | -23.0% |
| Stockholders' Equity | -$401K | -101.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$18.9M | -47.1% |
| Capital Expenditures | $250K | +0.4% |
| Investing Cash Flow | -$250K | -0.4% |
| Financing Cash Flow | -$156K | -100.3% |
| Free Cash Flow | -$19.1M | -46.2% |